Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum
First-line anti-PD-1 therapy combined with chemotherapy demonstrated favorable real-world outcomes in ESCC. The proposed prognostic scoring system may help personalize treatment strategies.
Authors
- Seyoung Seo (ORCID: https://orcid.org/0000-0003-1201-3194)
- Sook Ryun Park (ORCID: https://orcid.org/0000-0003-4724-5016)
- Min Hee Hong (ORCID: https://orcid.org/0000-0003-3490-2195)
- Jiyun Jeong
- Minkyu Jung (ORCID: https://orcid.org/0000-0001-8281-3387)
- Hye Ryun Kim (ORCID: https://orcid.org/0000-0002-1842-9070)
- Chang Gon Kim (ORCID: https://orcid.org/0000-0002-4929-8501)
- Moonki Hong (ORCID: https://orcid.org/0000-0001-9528-4912)
- Byoung Chul Cho (ORCID: https://orcid.org/0000-0002-5562-270X)
- Joon Seon Song (ORCID: https://orcid.org/0000-0002-7429-4254)
- Sung-Bae Kim
Institutions
- Yonsei University (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-28
- DOI
- https://doi.org/10.3390/cancers17193149
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00